ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Higher IL10 Production by Transitional B Cells in Tolerant Kidney Transplant Recipients

E. Nova Lamperti, P. Mobillo, Y. Kamra, G. Lord, R. Lechler, G. Lombardi, GAMBIT Consortium, M. Hernandez Fuentes

Experimental Immunobiology, King's College London, London, United Kingdom
Immunoregulation &
Immune Intervention, King's College London, London, United Kingdom
King's Health Partners, King's College London, London, United Kingdom
Immune Tolerance Network, Indices of Tolerance Consortium

Meeting: 2013 American Transplant Congress

Abstract number: B1130

Related Abstracts
  • B Cells from Operational Tolerant Produce More IL10, Display a Defect of Late Differentiation and Harbor a Higher Susceptibility to Cell Death Apoptosis
  • Tolerant Kidney Transplant Patients Display B Cells With Regulatory Properties

Transplantation tolerance reduces the risk of infection, malignancy and cardiovascular disease caused by immunosupresive drugs. Indices of Tolerance revealed that tolerant kidney transplant recipients had an expansion of Bcells in peripheral blood. In parallel, a Bcell subset with regulatory properties has been described in humans as a transitional Bcell, characterised by high expression of CD38/24 and IL10 production. We set out to test the hypothesis that the expansion of this B cell subset was central in the process of spontaneous tolerance observed in these rare recipients and to test the ability of these cells to present alloantigens. Tolerant:functionally stable recipients without immunosuppressive drugs, stable:functionally stable recipients on standard immunosuppression, chronic rejector:immunosuppressed recipients that presented signs of chronic rejection and healthy controls samples were used in the study. Bcell subsets from patients were identified by flow cytometry with ΑCD20, ΑCD19, ΑCD27, ΑIgM, ΑIgG, ΑCD24 & ΑCD38. PBMCs were cultured 3 days alone, with CD40L and CpG, activation markers were measured by surface staining and IL10, IFN-Γ/TNF-Α were measured by flow and ELISA. Bcells were identified as CD20CD19 and memory B cells as CD27+. Within the CD27- non-memory Bcells we selected the IgDIgM population to study the non-class-switching Bcells and then we identified Transitional Bcells as CD24hiCD38hi. Within the CD27- population, transitional Bcells were more prevalent in tolerant patients (9,7%), in comparison with stable patients (2,4%), chronic rejectors (2,0%) and healthy controls (11,5%). Bcells from all groups of patients increased activation markers and TLR-9 after CD40L and CpG activation, respectively. Tolerant patients displayed a higher percentage of IL10+ Bcells in comparison with the rest of the groups in response to CD40L and CpG. CD40L interaction with Bcells occurs after encounter with activated Tcells. Only in this context Bcells from tolerant recipients were producing higher amounts of IL-10. This is a first step towards a firm link between an expansion of transitional Bcells and transplantation tolerance. Further studies are under way, to establish alloantigen specificity in this interaction.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lamperti ENova, Mobillo P, Kamra Y, Lord G, Lechler R, Lombardi G, Consortium GAMBIT, Fuentes MHernandez. Higher IL10 Production by Transitional B Cells in Tolerant Kidney Transplant Recipients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/higher-il10-production-by-transitional-b-cells-in-tolerant-kidney-transplant-recipients/. Accessed April 22, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.